TY - JOUR
T1 - Methods for cell- and tissue-specific DNA aptamer selection
AU - Wilbanks, Brandon A.
AU - Doherty, Caroline D.
AU - Pearson, Keenan S.
AU - Jain, Sonia
AU - Sarkaria, Jann N.
AU - Maher, L. James
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/6/12
Y1 - 2025/6/12
N2 - Aptamers are folded single-stranded DNA or RNA molecules with high affinity for target small molecules, proteins, cells, or tissues. Affinity arises from the three-dimensional structure of the aptamer. Many significant advancements in oligonucleotide selection strategies have been made since the first foundational reports of in vitro selection techniques over 30 years ago. Most notably, the last 15 years have seen major advancements in selection protocols for aptamers with affinity to unspecified targets in complex living mammalian contexts such as cultured cells or tissues and tumors in live animals. Chemically unmodified DNA aptamers have potential as low-cost, biodegradable drug delivery or diagnostic reagents offering highly specific interactions against targeted cell populations. Here, we provide routine protocols from our labs for design and implementation of aptamer selections against cells or tissues, including principles of library design, selection strategy, aptamer candidate identification, and complementary image- and qPCR-based techniques for validating aptamer specificity.
AB - Aptamers are folded single-stranded DNA or RNA molecules with high affinity for target small molecules, proteins, cells, or tissues. Affinity arises from the three-dimensional structure of the aptamer. Many significant advancements in oligonucleotide selection strategies have been made since the first foundational reports of in vitro selection techniques over 30 years ago. Most notably, the last 15 years have seen major advancements in selection protocols for aptamers with affinity to unspecified targets in complex living mammalian contexts such as cultured cells or tissues and tumors in live animals. Chemically unmodified DNA aptamers have potential as low-cost, biodegradable drug delivery or diagnostic reagents offering highly specific interactions against targeted cell populations. Here, we provide routine protocols from our labs for design and implementation of aptamer selections against cells or tissues, including principles of library design, selection strategy, aptamer candidate identification, and complementary image- and qPCR-based techniques for validating aptamer specificity.
KW - DNA aptamer
KW - aptamer characterization
KW - cell selection
KW - deep sequencing
KW - in vivo selection
UR - http://www.scopus.com/inward/record.url?scp=105004310568&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105004310568&partnerID=8YFLogxK
U2 - 10.1016/j.omtm.2025.101482
DO - 10.1016/j.omtm.2025.101482
M3 - Article
AN - SCOPUS:105004310568
SN - 2329-0501
VL - 33
JO - Molecular Therapy Methods and Clinical Development
JF - Molecular Therapy Methods and Clinical Development
IS - 2
M1 - 101482
ER -